Liu X - Search Results

1

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.

Li G, Li Y, Liu X, Wang Z, Zhang C, Wu F, Jiang H, Zhang W, Bao Z, Wang Y, Cai J, Zhao L, Kahlert UD, Jiang T, Zhang W. Li G, et al. Among authors: liu x. Cell Death Dis. 2018 Dec 11;9(12):1190. doi: 10.1038/s41419-018-1232-3. Cell Death Dis. 2018. PMID: 30538217 Free PMC article.

2

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.

Li G, Wang Z, Zhang C, Liu X, Yang F, Sun L, Liang J, Hu H, Liu Y, You G, Bao Z, Zhang W, Wang Z, Jiang T. Li G, et al. Among authors: liu y, liu x. Dis Markers. 2018 May 20;2018:5975216. doi: 10.1155/2018/5975216. eCollection 2018. Dis Markers. 2018. PMID: 29887919 Free PMC article.

3

FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.

Wang Z, Zhang C, Sun L, Liang J, Liu X, Li G, Yao K, Zhang W, Jiang T. Wang Z, et al. Among authors: liu x. Oncotarget. 2016 Dec 20;7(51):84587-84593. doi: 10.18632/oncotarget.13139. Oncotarget. 2016. PMID: 27829236 Free PMC article.

4

miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.

Yang F, Liu X, Liu Y, Liu Y, Zhang C, Wang Z, Jiang T, Wang Y. Yang F, et al. Among authors: liu y, liu x. Cancer Lett. 2017 Jun 28;396:1-9. doi: 10.1016/j.canlet.2017.03.002. Epub 2017 Mar 9. Cancer Lett. 2017. PMID: 28286260

5

Tumor Purity as an Underlying Key Factor in Glioma.

Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G, Han S, Jiang T, Wu A. Zhang C, et al. Among authors: liu x. Clin Cancer Res. 2017 Oct 15;23(20):6279-6291. doi: 10.1158/1078-0432.CCR-16-2598. Epub 2017 Jul 28. Clin Cancer Res. 2017. PMID: 28754819

6

Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples.

Li G, Wang Z, Zhang C, Liu X, Cai J, Wang Z, Hu H, Wu F, Bao Z, Liu Y, Zhao L, Liang T, Yang F, Huang R, Zhang W, Jiang T. Li G, et al. Among authors: liu y, liu x. Oncoimmunology. 2017 Jul 28;6(8):e1328339. doi: 10.1080/2162402X.2017.1328339. eCollection 2017. Oncoimmunology. 2017. PMID: 28919992 Free PMC article.

7

Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.

Qian Z, Li Y, Fan X, Zhang C, Wang Y, Jiang T, Liu X. Qian Z, et al. Among authors: liu x. J Neurooncol. 2018 Mar;137(1):127-137. doi: 10.1007/s11060-017-2704-5. Epub 2017 Dec 4. J Neurooncol. 2018. PMID: 29204839

8

Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.

Wang Z, Wang Z, Zhang C, Liu X, Li G, Liu S, Sun L, Liang J, Hu H, Liu Y, Zhang W, Jiang T. Wang Z, et al. Among authors: liu y, liu x, liu s. Cancer Sci. 2018 Sep;109(9):2697-2705. doi: 10.1111/cas.13744. Epub 2018 Aug 29. Cancer Sci. 2018. PMID: 30027617 Free PMC article.

9

Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.

Liu YQ, Chai RC, Wang YZ, Wang Z, Liu X, Wu F, Jiang T. Liu YQ, et al. Among authors: liu x. Cancer Sci. 2019 Jan;110(1):321-333. doi: 10.1111/cas.13878. Epub 2018 Dec 17. Cancer Sci. 2019. PMID: 30431206 Free PMC article.

10

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.

Liu YQ, Wu F, Li JJ, Li YF, Liu X, Wang Z, Chai RC. Liu YQ, et al. Among authors: liu x. Front Oncol. 2019 Dec 17;9:1433. doi: 10.3389/fonc.2019.01433. eCollection 2019. Front Oncol. 2019. PMID: 31921684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,055 results

Search Page

Filters